The impact of anti-angiogenic agents on cancer therapy.
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004730:Endothelium, Vascular / Q000187:drug effects; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy; D018919:Neovascularization, Physiologic
D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents